Zoledronic Acid (ZOMETA) With Cyclophosphamide With Neuroblastoma and Cortical Bone Involvement
This study is ongoing, but not recruiting participants.
Sponsor:
Baylor College of Medicine
Collaborator:
New Approaches to Neuroblastoma Therapy Consortium
Information provided by (Responsible Party):
Peter Zage, Baylor College of Medicine
ClinicalTrials.gov Identifier:
NCT00206388
First received: September 14, 2005
Last updated: May 14, 2012
Last verified: May 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | August 2014 |
| Primary Completion Date: | April 2008 (Final data collection date for primary outcome measure) |